Saturday 17 October 2026
Export GRDN’s income statement to Excel — free account
Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.16%, EPS grew 133.3% and free cash flow grew 60.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
39.41
0.27
−0.68%
Follow GRDN
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | 14.16 | 17.78 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | 25.74 | 37.43 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 3,200 | 3,400 | 3,600 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.33 | 0.36 | 0.40 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 1,046 | 1,228 | 1,449 | ||||
| Gross margin, % | — | — | — | — | — | — | — | 19.91 | 19.89 | 20.21 | |||||
| EBT | — | — | — | — | — | — | — | 38 | (66) | 73 | |||||
| EBT margin, % | — | — | — | — | — | — | — | 3.61 | (5.41) | 5.07 | |||||
| Net income | — | — | — | — | — | — | — | 38 | (71) | 49 | |||||
| Depreciation | — | — | — | — | — | — | — | 18 | 20 | 22 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | 0.00 | 19.81 | 23.22 | ||||
| Earnings | — | — | — | — | — | — | — | — | (1.77) | 0.79 | |||||
| Cash flow | — | — | — | — | — | — | — | 0.00 | 0.93 | 1.61 | |||||
| Capex | — | — | — | — | — | — | — | 0.00 | (0.26) | (0.31) | |||||
| Free cash flow | — | — | — | — | — | — | — | 0.00 | 0.67 | 1.29 | |||||
| Book value | — | — | — | — | — | — | — | 0.00 | 2.42 | 3.49 | |||||
| Shares, m | — | — | — | — | — | — | — | 0 | 62 | 62 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 38.09 | ||||
| P/S | — | — | — | — | — | — | — | 0.00 | 1.02 | 1.30 | |||||
| P/B | — | — | — | — | — | — | — | 0.00 | 8.38 | 8.61 | |||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 1.05 | 1.28 | |||||
| EV/FCF | — | — | — | — | — | — | — | 0.00 | 31.02 | 22.92 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | 71 | 58 | 100 | ||||
| Capex | — | — | — | — | — | — | — | (15) | (16) | (20) | |||||
| Free cash flow | — | — | — | — | — | — | — | 56 | 42 | 81 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | (8) | 8 | 61 | ||||
| Total debt | — | — | — | — | — | — | — | 28 | — | — | |||||
| Net debt | — | — | — | — | — | — | — | 27 | (5) | (66) | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | 60 | 150 | 218 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | (37.18) | 13.42 | ||||
| ROIC | — | — | — | — | — | — | — | 29.38 | (27.06) | 29.83 | |||||
| ROE | — | — | — | — | — | — | — | — | (104.89) | 26.76 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Guardian Pharmacy Services, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company, Inc. | $2.9B | — (loss-making) | 21.1× | −0.39% (below 0%: shrinking) | −63.64% (below 0%: shrinking) | +856.54% (above 0%: growing) | 100.00% | 10.14% | Compare |
| AVAH Aveanna Healthcare Holdings Inc. | $2.8B | 9.5× | 10.4× | +13.73% (above 0%: growing) | +46.15% (above 0%: growing) | +57.89% (above 0%: growing) | 32.59% | 11.93% | Compare |
| GRDN Guardian Pharmacy Services, Inc. | $2.5B | 37.5× | 39.5× | +2.16% (above 0%: growing) | +133.33% (above 0%: growing) | +60.83% (above 0%: growing) | 22.75% | 5.87% | |
| BKD Brookdale Senior Living Inc. | $2.4B | — (loss-making) | — (loss-making) | −11.61% (below 0%: shrinking) | n/m | +533.14% (above 0%: growing) | 29.94% | 11.86% | Compare |
| MD Pediatrix Medical Group, Inc. | $2.3B | 13.1× | 11.3× | +4.04% (above 0%: growing) | +6.52% (above 0%: growing) | −6.56% (below 0%: shrinking) | 27.16% | 11.67% | Compare |
| ADUS Addus HomeCare Corporation | $2.2B | 20.4× | 14.9× | +8.01% (above 0%: growing) | +24.17% (above 0%: growing) | +81.74% (above 0%: growing) | 32.21% | 10.32% | Compare |
| SGRY Surgery Partners, Inc. | $1.9B | — (loss-making) | — (loss-making) | +2.75% (above 0%: growing) | n/m | −60.63% (below 0%: shrinking) | 22.41% | 12.78% | Compare |
| ASTH Astrana Health, Inc. | $1.9B | 44.3× | 29.7× | +48.52% (above 0%: growing) | +110.53% (above 0%: growing) | −67.74% (below 0%: shrinking) | 10.70% | 3.53% | Compare |
| ARDT Ardent Health, Inc. | $1.7B | 21.7× | 7.7× | −1.40% (below 0%: shrinking) | −76.92% (below 0%: shrinking) | +121.70% (above 0%: growing) | 100.00% | 3.44% | Compare |
| Median of peers | $2.2B | 20.4× | 13.1× | +3.40% | +15.35% | +69.82% | 31.07% | 10.99% |
Guardian Pharmacy Services, Inc. (GRDN) key facts
- Strength: Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Guardian Pharmacy Services, Inc. (GRDN) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
- As of October 16, 2026, GRDN traded at $39.41, a market capitalization of $2.5 billion.
- Return on equity was 26.8% and debt-to-equity 0.00.
- Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 10.28 (safe zone) for fiscal 2025.
Guardian Pharmacy Services, Inc. (GRDN) Latest News
No news at this impact. Lower the threshold for more.